Literature DB >> 32208945

Buprenorphine Field Initiation of ReScue Treatment by Emergency Medical Services (Bupe FIRST EMS): A Case Series.

Gerard G Carroll, Deena D Wasserman, Aman A Shah, Matthew S Salzman, Kaitlan E Baston, Rick A Rohrbach, Iris L Jones, Rachel Haroz.   

Abstract

The opioid epidemic is currently a leading health crisis in the United States, and evidence supports Medication for Opioid Use Disorder (MOUD) as the most effective treatment (2). In our EMS system we are observing an ever increasing number of patients who, due to refusing transport after naloxone rescue, represent an access void at the point of overdose. We present a case series to illustrate a new treatment paradigm utilizing front line EMS paramedic units and high dose buprenorphine to treat withdrawal symptoms with next day bridge to long term care. The three patients described are exemplary cases, meant to represent overall characteristics of the intervention prior to complete data collection. Each patient was revived from opioid overdose with naloxone. Paramedics then treated each patient with 16 mg of buprenorphine to relieve and prevent withdrawal symptoms. Patients were provided with outpatient follow up irrespective of ED transport. To the best of our knowledge, this is the first EMS agency in the United States providing MOUD in the prehospital setting at the point of overdose. This innovative program provides EMS with education and tools to promote patient engagement. While still in its infancy, this approach utilizes existing EMS resources to bring MOUD to the prehospital setting, offering a new avenue to long term care. Keywords: Opioid, buprenorphine, emergency medical services, medication assisted therapy, naloxone, overdose.

Entities:  

Year:  2020        PMID: 32208945     DOI: 10.1080/10903127.2020.1747579

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  5 in total

1.  Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.

Authors:  Stephen Crystal; Molly Nowels; Hillary Samples; Mark Olfson; Arthur Robin Williams; Peter Treitler
Journal:  Drug Alcohol Depend       Date:  2022-01-10       Impact factor: 4.492

Review 2.  Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.

Authors:  Bertha K Madras; N Jia Ahmad; Jenny Wen; Joshua Sharfstein Sharfstein
Journal:  NAM Perspect       Date:  2020-04-27

3.  Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.

Authors:  Corey S Davis; Derek H Carr; Melody J Glenn; Elizabeth A Samuels
Journal:  Ann Emerg Med       Date:  2021-03-27       Impact factor: 6.762

4.  Emergency department care for patients who use opioids during the COVID-19 pandemic.

Authors:  Sarah A Weicker; Kelsey A Speed; Elaine Hyshka; May Mrochuk; Brynn Kosteniuk; Kathryn Dong
Journal:  CJEM       Date:  2021-11-24       Impact factor: 2.929

5.  Emergency department-initiated buprenorphine protocols: A national evaluation.

Authors:  Clara Z Guo; Gail D'Onofrio; David A Fiellin; E Jennifer Edelman; Kathryn Hawk; Andrew Herring; Ryan McCormack; Jeanmarie Perrone; Ethan Cowan
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.